Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Ahmed obtained his medical degree from School of Medicine at University of Cairo in 1995 and his Ph.D. degree in Pharmacology & Toxicology from School of Pharmacy at University of Connecticut in 2006. Ahmed joined Biogen Idec in 2013, where his focus is to identify and implement innovative approaches to investigate clinical, radiographic and molecular variables associated with neurodegenerative disease heterogeneity, severity and progression trajectories. Ahmed was also a member of the Precision Medicine initiative leading patient stratification and response prediction studies in oncology and autoimmune diseases. Prior to Pfizer Ahmed was the personalized medicine lead scientist at Genstruct Inc. (now Selventa Inc.), where he led the application of causal reasoning systems biology approaches to profile cancer patients for therapy prioritization.
Drug discovery, Computational Biology, Bioinformatics, Cell biology, Biomarkers